RENOVORX INC. - COMMON STOCK

0,9980

31-октября-24 15:58:46

15 мин. задержка

Акции

-0,0020

-0,20%

Сегодняшний диапазон

0,9000 - 1,0000

ISIN

N/A

Источник

NASDAQ

RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians

25 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire
RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer

19 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire
RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York

27 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire
RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

14 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire
RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®

31 июл 2024 08:30:00 Источник Nasdaq GlobeNewswire
RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®

08 июл 2024 08:30:00 Источник Nasdaq GlobeNewswire
University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial

26 июн 2024 08:30:00 Источник Nasdaq GlobeNewswire
RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships

10 июн 2024 08:30:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.